Homburger advised ADC Therapeutics SA on the agreement.ADC Therapeutics SA (NYSE: ADCT), a Swiss-based commercial-stage oncology-focused biotechnology company, announced that it had entered into a royalty…
ADC Therapeutics’ $325 Million Royalty Purchase Agreement With HealthCare Royalty
